Orionis Biosciences Secures $55 Million Financing To Support Advancement Into Clinic
Amount Raised
$55 Million
Round Type
Funding Round
WalthamBiotechnologyHealth CareTherapeuticsDescription
Orionis Biosciences, a life sciences company pioneering innovation of highly selective and tunable therapeutics for cancer and beyond, today announced it has completed a $55 million financing round and expanded its team, naming Robert Petit, Ph.D., as Senior Vice President, Early Clinical Development and Bihua Chen to the Orionis Board of Directors.
Quick answer
Orionis Biosciences raised $55 Million in a Funding Round round, dated October 19, 2022. Orionis Biosciences is based in Waltham, Massachusetts, United States.
- How much did Orionis Biosciences raise?
- Orionis Biosciences raised $55 Million in a Funding Round round on October 19, 2022.
- What does Orionis Biosciences do?
- Orionis Biosciences is a life sciences company pioneering technological innovation in genome-scale drug discovery and tunable molecular design of novel therapeutic drug modalities.
- Where is Orionis Biosciences based and how big is it?
- Orionis Biosciences is based in Waltham, Massachusetts, United States.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Orionis Biosciences that raised within 45 days of this round, from Fundz verified event records.
- Solid Biosciences raised $9.2M on December 2, 2022.
- RE-VANA THERAPEUTICS raised $12M (Series A) on November 30, 2022.
- iECURE raised $65M (Funding Round) on November 30, 2022.
- Nectin Therapeutics raised an undisclosed amount (Series A) on November 30, 2022.
- Escient Pharmaceuticals raised $120M (Series C) on November 28, 2022.
- Parabilis Medicines raised $178M (Series D) on November 21, 2022.
Who to call at Orionis Biosciences, and when
A new round usually means Orionis Biosciences is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Orionis Biosciences raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Orionis Biosciences, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Orionis Biosciences. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Orionis Biosciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Orionis Biosciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.